Cargando…

Adjuvant treatment can improve prognosis in patients with non-small cell lung cancer ≤3 cm after sublobectomy: a propensity score analysis

BACKGROUND: Numerous retrospective studies have reported that sublobectomy has a poorer prognosis than lobectomy in patients with early-stage lung cancer. The purpose of this study was to determine whether adjuvant treatment could improve the prognosis of patients with non-small cell lung cancer (NS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Haibo, Cheng, Jiwei, Yu, Yongkui, Liu, Baoxing, Qin, Jianjun, Xing, Wenqun, Luo, Suxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867827/ https://www.ncbi.nlm.nih.gov/pubmed/33569211 http://dx.doi.org/10.21037/jtd-20-3448

Ejemplares similares

Older patients more likely to die from cancer-related diseases than younger with stage IA non-small cell lung cancer: a SEER database analysis
por: Ma, Haibo, et al.
Publicado: (2022)

Functional Preserving Sublobectomy: A Novel Method for Sublobectomy
por: Zhang, Min, et al.
Publicado: (2021)

Development and External Validation of a Nomogram for Predicting Survival in Patients With Stage IA Non-small Cell Lung Cancer ≤2 cm Undergoing Sublobectomy
por: Wo, Yang, et al.
Publicado: (2019)

Clinical analysis of the impact of sublobectomy on pulmonary function
por: Yang, Haiping, et al.
Publicado: (2017)

Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis
por: Yang, Yong, et al.
Publicado: (2021)

Lobectomy vs. sublobectomy for stage I non-small-cell lung cancer: a meta-analysis
por: Lv, Fang, et al.
Publicado: (2021)

microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer
por: Li, Peng, et al.
Publicado: (2019)

Impact of Surgical Margin on the Prognosis of Early Hepatocellular Carcinoma (≤5 cm): A Propensity Score Matching Analysis
por: Wang, Han, et al.
Publicado: (2020)

Treatment outcomes of surgery and chemotherapy for pulmonary metastases from non-lung cancers: a propensity score-matched analysis
por: Gao, Kun, et al.
Publicado: (2023)

Ultrasound location of pulmonary nodules in video‐assisted thoracoscopic surgery for precise sublobectomy
por: Hou, Yue‐Long, et al.
Publicado: (2020)

Knockdown of lncRNA XIST Suppresses Cell Tumorigenicity in Human Non-Small Cell Lung Cancer by Regulating miR-142-5p/PAX6 Axis
por: Jiang, Qingfeng, et al.
Publicado: (2020)

Neoadjuvant therapy combined with surgery is superior to chemoradiotherapy in esophageal squamous cell cancer patients with resectable supraclavicular lymph node metastasis: a propensity score-matched analysis
por: Yu, Yongkui, et al.
Publicado: (2022)

Comparison of surgical outcomes and prognosis between wedge resection and simple Segmentectomy for GGO diameter between 2 cm and 3 cm in non-small cell lung cancer: a multicenter and propensity score matching analysis
por: Zhou, Yaodong, et al.
Publicado: (2022)

Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study
por: Yu, Yue, et al.
Publicado: (2020)

Sublobectomy versus Lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study
por: Liu, Yaxin, et al.
Publicado: (2014)

Lobectomy Versus Sublobectomy in Stage IIIA/N2 Non-Small Cell Lung Cancer: A Population-Based Study
por: Wang, Suyu, et al.
Publicado: (2021)

THAP9-AS1/miR-133b/SOX4 positive feedback loop facilitates the progression of esophageal squamous cell carcinoma
por: Cheng, Jiwei, et al.
Publicado: (2021)

The T stage of esophageal cancer can be effectively predicted by muscularis propria thickness and muscularis propria + mucosa thickness under ultrasonic gastroscopy
por: Yu, Yongkui, et al.
Publicado: (2022)

Sublobectomy for stage IA1‐2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25
por: Qi, Yi‐Fan, et al.
Publicado: (2022)

V7 ENB‐guided thoracoscopic sublobectomy for stage IA synchronous multiple primary lung cancer
por: Wang, Kun, et al.
Publicado: (2022)

Lobectomy versus segmentectomy in patients with stage T (> 2 cm and ≤ 3 cm) N0M0 non-small cell lung cancer: a propensity score matching study
por: Wang, Linlin, et al.
Publicado: (2022)

Long Non-Coding RNA TP73-AS1 Promotes the Development of Lung Cancer by Targeting the miR-27b-3p/LAPTM4B Axis
por: Jiang, Qingfeng, et al.
Publicado: (2020)

Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China
por: Wu, Zhao, et al.
Publicado: (2023)

The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023)

Comparison of postoperative cough-related quality of life and recovery between sublobectomy and lobectomy for early-stage non-small cell lung cancer patients: a longitudinal study
por: Lin, Rongjia, et al.
Publicado: (2022)

A Matched Comparison Study of Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early-stage Nonsmall Cell Lung Cancer
por: Mu, Ju-Wei, et al.
Publicado: (2015)

Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based Versus Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma
por: Zheng, Yan, et al.
Publicado: (2021)

The impact of thrombocytopenia on prognosis of HBV-related small hepatocellular carcinoma: a propensity score matching analysis
por: Peng, Wei, et al.
Publicado: (2021)

Functional outcome and Health-related Quality of life two years after lobectomy and sublobectomy for early stage non-small cell lung cancer: A New Center Experience
por: Ali Elshorbagy, Ashraf Ali Mohammed, et al.
Publicado: (2015)

Uniportal VATS lobectomy versus thoracotomy lobectomy for NSCLC larger than 5 cm: A propensity score‐matched study
por: Liu, Jingwei, et al.
Publicado: (2022)

Prediction of Post-resection Prognosis Using the ADV Score for Huge Hepatocellular Carcinomas ≥13 cm
por: Hwang, Shin, et al.
Publicado: (2021)

Prognosis analysis of lobectomy and sublobar resection in patients ≥75 years old with pathological stage I invasive lung adenocarcinoma of ≤3 cm: a propensity score matching-based analysis
por: Chen, Chunji, et al.
Publicado: (2019)

A Novel Risk-Scoring System to Identify the Potential Population Benefiting From Adjuvant Chemotherapy for Node-Negative TNBC Patients With Tumor Size Less Than 1 cm
por: Li, Yijun, et al.
Publicado: (2022)

A clinical nomogram for predicting tumor regression grade in esophageal squamous-cell carcinoma treated with immune neoadjuvant immunotherapy
por: Yu, Yongkui, et al.
Publicado: (2022)

Serum Fibrinogen Is An Independent Prognostic Factor In Operable Esophageal Squamous Carcinoma: A Real-World Study
por: Zheng, Yan, et al.
Publicado: (2019)

The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis
por: Zhou, Kai, et al.
Publicado: (2020)

Robot-Assisted versus Laparoscopic Partial Nephrectomy for Giant Sporadic Renal Angiomyolipomas of ≥7 cm: A Propensity Score-Matched Analysis
por: Xiong, Yunqiang, et al.
Publicado: (2021)

Impact of Surgery on Non-Functional Pancreatic Neuroendocrine Tumors ≤2 cm: Analyses With Propensity Score–Based Inverse Probability of Treatment Weighting
por: Ye, Jingyuan, et al.
Publicado: (2022)

Silencing lncRNA AGAP2-AS1 Upregulates miR-195-5p to Repress Migration and Invasion of EC Cells via the Decrease of FOSL1 Expression
por: Shen, Sining, et al.
Publicado: (2020)

Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study
por: Huang, Qizhen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fa5g1ftu0olslej4d3l4ncku48